COVID-19 Impact on Global Gefitinib Market Insights, Forecast to 2026
![](/report_cover/6975/covid-19-impact-on-global-gefitinib-market-insights-forecast-to-2026_en.gif)
Gefitinib market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gefitinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Gefitinib market is segmented into
The Gefitinib market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gefitinib market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gefitinib Market Share Analysis
Gefitinib market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gefitinib business, the date to enter into the Gefitinib market, Gefitinib product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Gefitinib market is segmented into
- 10 Tables/Box
- 30 Tables/Box
- 90 Tables/Box
- Hospital
- Clinic
- Drug Center
- Other
The Gefitinib market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gefitinib market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gefitinib Market Share Analysis
Gefitinib market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gefitinib business, the date to enter into the Gefitinib market, Gefitinib product introduction, recent developments, etc.
The major vendors covered:
- AstraZeneca
- Qilu Pharmaceutical
- Natco Pharma
- Celon Laboratories
- Hetero Drugs
- Dr Reddy's Laboratories
- Zuventus Healthcare
- United Biotech
- Panacea Biotec
- Cipla
- Glenmark Pharmaceuticals
- Nobel Ilac Sanayii Ve Ticaret
- Accure Labs
- Cadila Pharmaceuticals
- Ethypharm
- Flagship Biotech International
- Globela Pharma
- Jodas Expoim
- Nishchay Pharmaceuticals
- Sichuan Xieli Pharmaceutical
1 STUDY COVERAGE
1.1 Gefitinib Product Introduction
1.2 Market Segments
1.3 Key Gefitinib Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gefitinib Market Size Growth Rate by Type
1.4.2 10 Tables/Box
1.4.3 30 Tables/Box
1.4.4 90 Tables/Box
1.5 Market by Application
1.5.1 Global Gefitinib Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Drug Center
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Gefitinib Industry Impact
1.6.1 How the Covid-19 is Affecting the Gefitinib Industry
1.6.1.1 Gefitinib Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gefitinib Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gefitinib Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Gefitinib Market Size Estimates and Forecasts
2.1.1 Global Gefitinib Revenue 2015-2026
2.1.2 Global Gefitinib Sales 2015-2026
2.2 Gefitinib Market Size by Region: 2020 Versus 2026
2.2.1 Global Gefitinib Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Gefitinib Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL GEFITINIB COMPETITOR LANDSCAPE BY PLAYERS
3.1 Gefitinib Sales by Manufacturers
3.1.1 Gefitinib Sales by Manufacturers (2015-2020)
3.1.2 Gefitinib Sales Market Share by Manufacturers (2015-2020)
3.2 Gefitinib Revenue by Manufacturers
3.2.1 Gefitinib Revenue by Manufacturers (2015-2020)
3.2.2 Gefitinib Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gefitinib Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gefitinib Revenue in 2019
3.2.5 Global Gefitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Gefitinib Price by Manufacturers
3.4 Gefitinib Manufacturing Base Distribution, Product Types
3.4.1 Gefitinib Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gefitinib Product Type
3.4.3 Date of International Manufacturers Enter into Gefitinib Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Gefitinib Market Size by Type (2015-2020)
4.1.1 Global Gefitinib Sales by Type (2015-2020)
4.1.2 Global Gefitinib Revenue by Type (2015-2020)
4.1.3 Gefitinib Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gefitinib Market Size Forecast by Type (2021-2026)
4.2.1 Global Gefitinib Sales Forecast by Type (2021-2026)
4.2.2 Global Gefitinib Revenue Forecast by Type (2021-2026)
4.2.3 Gefitinib Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gefitinib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Gefitinib Market Size by Application (2015-2020)
5.1.1 Global Gefitinib Sales by Application (2015-2020)
5.1.2 Global Gefitinib Revenue by Application (2015-2020)
5.1.3 Gefitinib Price by Application (2015-2020)
5.2 Gefitinib Market Size Forecast by Application (2021-2026)
5.2.1 Global Gefitinib Sales Forecast by Application (2021-2026)
5.2.2 Global Gefitinib Revenue Forecast by Application (2021-2026)
5.2.3 Global Gefitinib Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Gefitinib by Country
6.1.1 North America Gefitinib Sales by Country
6.1.2 North America Gefitinib Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Gefitinib Market Facts & Figures by Type
6.3 North America Gefitinib Market Facts & Figures by Application
7 EUROPE
7.1 Europe Gefitinib by Country
7.1.1 Europe Gefitinib Sales by Country
7.1.2 Europe Gefitinib Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gefitinib Market Facts & Figures by Type
7.3 Europe Gefitinib Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Gefitinib by Region
8.1.1 Asia Pacific Gefitinib Sales by Region
8.1.2 Asia Pacific Gefitinib Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Gefitinib Market Facts & Figures by Type
8.3 Asia Pacific Gefitinib Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Gefitinib by Country
9.1.1 Latin America Gefitinib Sales by Country
9.1.2 Latin America Gefitinib Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Gefitinib Market Facts & Figures by Type
9.3 Central & South America Gefitinib Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Gefitinib by Country
10.1.1 Middle East and Africa Gefitinib Sales by Country
10.1.2 Middle East and Africa Gefitinib Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Gefitinib Market Facts & Figures by Type
10.3 Middle East and Africa Gefitinib Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Gefitinib Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Qilu Pharmaceutical
11.2.1 Qilu Pharmaceutical Corporation Information
11.2.2 Qilu Pharmaceutical Description, Business Overview and Total Revenue
11.2.3 Qilu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Qilu Pharmaceutical Gefitinib Products Offered
11.2.5 Qilu Pharmaceutical Recent Development
11.3 Natco Pharma
11.3.1 Natco Pharma Corporation Information
11.3.2 Natco Pharma Description, Business Overview and Total Revenue
11.3.3 Natco Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Natco Pharma Gefitinib Products Offered
11.3.5 Natco Pharma Recent Development
11.4 Celon Laboratories
11.4.1 Celon Laboratories Corporation Information
11.4.2 Celon Laboratories Description, Business Overview and Total Revenue
11.4.3 Celon Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celon Laboratories Gefitinib Products Offered
11.4.5 Celon Laboratories Recent Development
11.5 Hetero Drugs
11.5.1 Hetero Drugs Corporation Information
11.5.2 Hetero Drugs Description, Business Overview and Total Revenue
11.5.3 Hetero Drugs Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Hetero Drugs Gefitinib Products Offered
11.5.5 Hetero Drugs Recent Development
11.6 Dr Reddy's Laboratories
11.6.1 Dr Reddy's Laboratories Corporation Information
11.6.2 Dr Reddy's Laboratories Description, Business Overview and Total Revenue
11.6.3 Dr Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dr Reddy's Laboratories Gefitinib Products Offered
11.6.5 Dr Reddy's Laboratories Recent Development
11.7 Zuventus Healthcare
11.7.1 Zuventus Healthcare Corporation Information
11.7.2 Zuventus Healthcare Description, Business Overview and Total Revenue
11.7.3 Zuventus Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Zuventus Healthcare Gefitinib Products Offered
11.7.5 Zuventus Healthcare Recent Development
11.8 United Biotech
11.8.1 United Biotech Corporation Information
11.8.2 United Biotech Description, Business Overview and Total Revenue
11.8.3 United Biotech Sales, Revenue and Gross Margin (2015-2020)
11.8.4 United Biotech Gefitinib Products Offered
11.8.5 United Biotech Recent Development
11.9 Panacea Biotec
11.9.1 Panacea Biotec Corporation Information
11.9.2 Panacea Biotec Description, Business Overview and Total Revenue
11.9.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Panacea Biotec Gefitinib Products Offered
11.9.5 Panacea Biotec Recent Development
11.10 Cipla
11.10.1 Cipla Corporation Information
11.10.2 Cipla Description, Business Overview and Total Revenue
11.10.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Cipla Gefitinib Products Offered
11.10.5 Cipla Recent Development
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Gefitinib Products Offered
11.1.5 AstraZeneca Recent Development
11.12 Nobel Ilac Sanayii Ve Ticaret
11.12.1 Nobel Ilac Sanayii Ve Ticaret Corporation Information
11.12.2 Nobel Ilac Sanayii Ve Ticaret Description, Business Overview and Total Revenue
11.12.3 Nobel Ilac Sanayii Ve Ticaret Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Nobel Ilac Sanayii Ve Ticaret Products Offered
11.12.5 Nobel Ilac Sanayii Ve Ticaret Recent Development
11.13 Accure Labs
11.13.1 Accure Labs Corporation Information
11.13.2 Accure Labs Description, Business Overview and Total Revenue
11.13.3 Accure Labs Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Accure Labs Products Offered
11.13.5 Accure Labs Recent Development
11.14 Cadila Pharmaceuticals
11.14.1 Cadila Pharmaceuticals Corporation Information
11.14.2 Cadila Pharmaceuticals Description, Business Overview and Total Revenue
11.14.3 Cadila Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Cadila Pharmaceuticals Products Offered
11.14.5 Cadila Pharmaceuticals Recent Development
11.15 Ethypharm
11.15.1 Ethypharm Corporation Information
11.15.2 Ethypharm Description, Business Overview and Total Revenue
11.15.3 Ethypharm Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Ethypharm Products Offered
11.15.5 Ethypharm Recent Development
11.16 Flagship Biotech International
11.16.1 Flagship Biotech International Corporation Information
11.16.2 Flagship Biotech International Description, Business Overview and Total Revenue
11.16.3 Flagship Biotech International Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Flagship Biotech International Products Offered
11.16.5 Flagship Biotech International Recent Development
11.17 Globela Pharma
11.17.1 Globela Pharma Corporation Information
11.17.2 Globela Pharma Description, Business Overview and Total Revenue
11.17.3 Globela Pharma Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Globela Pharma Products Offered
11.17.5 Globela Pharma Recent Development
11.18 Jodas Expoim
11.18.1 Jodas Expoim Corporation Information
11.18.2 Jodas Expoim Description, Business Overview and Total Revenue
11.18.3 Jodas Expoim Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Jodas Expoim Products Offered
11.18.5 Jodas Expoim Recent Development
11.19 Nishchay Pharmaceuticals
11.19.1 Nishchay Pharmaceuticals Corporation Information
11.19.2 Nishchay Pharmaceuticals Description, Business Overview and Total Revenue
11.19.3 Nishchay Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Nishchay Pharmaceuticals Products Offered
11.19.5 Nishchay Pharmaceuticals Recent Development
11.20 Sichuan Xieli Pharmaceutical
11.20.1 Sichuan Xieli Pharmaceutical Corporation Information
11.20.2 Sichuan Xieli Pharmaceutical Description, Business Overview and Total Revenue
11.20.3 Sichuan Xieli Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Sichuan Xieli Pharmaceutical Products Offered
11.20.5 Sichuan Xieli Pharmaceutical Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Gefitinib Market Estimates and Projections by Region
12.1.1 Global Gefitinib Sales Forecast by Regions 2021-2026
12.1.2 Global Gefitinib Revenue Forecast by Regions 2021-2026
12.2 North America Gefitinib Market Size Forecast (2021-2026)
12.2.1 North America: Gefitinib Sales Forecast (2021-2026)
12.2.2 North America: Gefitinib Revenue Forecast (2021-2026)
12.2.3 North America: Gefitinib Market Size Forecast by Country (2021-2026)
12.3 Europe Gefitinib Market Size Forecast (2021-2026)
12.3.1 Europe: Gefitinib Sales Forecast (2021-2026)
12.3.2 Europe: Gefitinib Revenue Forecast (2021-2026)
12.3.3 Europe: Gefitinib Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Gefitinib Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Gefitinib Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Gefitinib Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Gefitinib Market Size Forecast by Region (2021-2026)
12.5 Latin America Gefitinib Market Size Forecast (2021-2026)
12.5.1 Latin America: Gefitinib Sales Forecast (2021-2026)
12.5.2 Latin America: Gefitinib Revenue Forecast (2021-2026)
12.5.3 Latin America: Gefitinib Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Gefitinib Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Gefitinib Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Gefitinib Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Gefitinib Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Gefitinib Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Gefitinib Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Gefitinib Product Introduction
1.2 Market Segments
1.3 Key Gefitinib Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gefitinib Market Size Growth Rate by Type
1.4.2 10 Tables/Box
1.4.3 30 Tables/Box
1.4.4 90 Tables/Box
1.5 Market by Application
1.5.1 Global Gefitinib Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Drug Center
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Gefitinib Industry Impact
1.6.1 How the Covid-19 is Affecting the Gefitinib Industry
1.6.1.1 Gefitinib Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gefitinib Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gefitinib Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Gefitinib Market Size Estimates and Forecasts
2.1.1 Global Gefitinib Revenue 2015-2026
2.1.2 Global Gefitinib Sales 2015-2026
2.2 Gefitinib Market Size by Region: 2020 Versus 2026
2.2.1 Global Gefitinib Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Gefitinib Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL GEFITINIB COMPETITOR LANDSCAPE BY PLAYERS
3.1 Gefitinib Sales by Manufacturers
3.1.1 Gefitinib Sales by Manufacturers (2015-2020)
3.1.2 Gefitinib Sales Market Share by Manufacturers (2015-2020)
3.2 Gefitinib Revenue by Manufacturers
3.2.1 Gefitinib Revenue by Manufacturers (2015-2020)
3.2.2 Gefitinib Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gefitinib Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gefitinib Revenue in 2019
3.2.5 Global Gefitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Gefitinib Price by Manufacturers
3.4 Gefitinib Manufacturing Base Distribution, Product Types
3.4.1 Gefitinib Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gefitinib Product Type
3.4.3 Date of International Manufacturers Enter into Gefitinib Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Gefitinib Market Size by Type (2015-2020)
4.1.1 Global Gefitinib Sales by Type (2015-2020)
4.1.2 Global Gefitinib Revenue by Type (2015-2020)
4.1.3 Gefitinib Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gefitinib Market Size Forecast by Type (2021-2026)
4.2.1 Global Gefitinib Sales Forecast by Type (2021-2026)
4.2.2 Global Gefitinib Revenue Forecast by Type (2021-2026)
4.2.3 Gefitinib Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gefitinib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Gefitinib Market Size by Application (2015-2020)
5.1.1 Global Gefitinib Sales by Application (2015-2020)
5.1.2 Global Gefitinib Revenue by Application (2015-2020)
5.1.3 Gefitinib Price by Application (2015-2020)
5.2 Gefitinib Market Size Forecast by Application (2021-2026)
5.2.1 Global Gefitinib Sales Forecast by Application (2021-2026)
5.2.2 Global Gefitinib Revenue Forecast by Application (2021-2026)
5.2.3 Global Gefitinib Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Gefitinib by Country
6.1.1 North America Gefitinib Sales by Country
6.1.2 North America Gefitinib Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Gefitinib Market Facts & Figures by Type
6.3 North America Gefitinib Market Facts & Figures by Application
7 EUROPE
7.1 Europe Gefitinib by Country
7.1.1 Europe Gefitinib Sales by Country
7.1.2 Europe Gefitinib Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gefitinib Market Facts & Figures by Type
7.3 Europe Gefitinib Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Gefitinib by Region
8.1.1 Asia Pacific Gefitinib Sales by Region
8.1.2 Asia Pacific Gefitinib Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Gefitinib Market Facts & Figures by Type
8.3 Asia Pacific Gefitinib Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Gefitinib by Country
9.1.1 Latin America Gefitinib Sales by Country
9.1.2 Latin America Gefitinib Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Gefitinib Market Facts & Figures by Type
9.3 Central & South America Gefitinib Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Gefitinib by Country
10.1.1 Middle East and Africa Gefitinib Sales by Country
10.1.2 Middle East and Africa Gefitinib Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Gefitinib Market Facts & Figures by Type
10.3 Middle East and Africa Gefitinib Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Gefitinib Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Qilu Pharmaceutical
11.2.1 Qilu Pharmaceutical Corporation Information
11.2.2 Qilu Pharmaceutical Description, Business Overview and Total Revenue
11.2.3 Qilu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Qilu Pharmaceutical Gefitinib Products Offered
11.2.5 Qilu Pharmaceutical Recent Development
11.3 Natco Pharma
11.3.1 Natco Pharma Corporation Information
11.3.2 Natco Pharma Description, Business Overview and Total Revenue
11.3.3 Natco Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Natco Pharma Gefitinib Products Offered
11.3.5 Natco Pharma Recent Development
11.4 Celon Laboratories
11.4.1 Celon Laboratories Corporation Information
11.4.2 Celon Laboratories Description, Business Overview and Total Revenue
11.4.3 Celon Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celon Laboratories Gefitinib Products Offered
11.4.5 Celon Laboratories Recent Development
11.5 Hetero Drugs
11.5.1 Hetero Drugs Corporation Information
11.5.2 Hetero Drugs Description, Business Overview and Total Revenue
11.5.3 Hetero Drugs Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Hetero Drugs Gefitinib Products Offered
11.5.5 Hetero Drugs Recent Development
11.6 Dr Reddy's Laboratories
11.6.1 Dr Reddy's Laboratories Corporation Information
11.6.2 Dr Reddy's Laboratories Description, Business Overview and Total Revenue
11.6.3 Dr Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dr Reddy's Laboratories Gefitinib Products Offered
11.6.5 Dr Reddy's Laboratories Recent Development
11.7 Zuventus Healthcare
11.7.1 Zuventus Healthcare Corporation Information
11.7.2 Zuventus Healthcare Description, Business Overview and Total Revenue
11.7.3 Zuventus Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Zuventus Healthcare Gefitinib Products Offered
11.7.5 Zuventus Healthcare Recent Development
11.8 United Biotech
11.8.1 United Biotech Corporation Information
11.8.2 United Biotech Description, Business Overview and Total Revenue
11.8.3 United Biotech Sales, Revenue and Gross Margin (2015-2020)
11.8.4 United Biotech Gefitinib Products Offered
11.8.5 United Biotech Recent Development
11.9 Panacea Biotec
11.9.1 Panacea Biotec Corporation Information
11.9.2 Panacea Biotec Description, Business Overview and Total Revenue
11.9.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Panacea Biotec Gefitinib Products Offered
11.9.5 Panacea Biotec Recent Development
11.10 Cipla
11.10.1 Cipla Corporation Information
11.10.2 Cipla Description, Business Overview and Total Revenue
11.10.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Cipla Gefitinib Products Offered
11.10.5 Cipla Recent Development
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Gefitinib Products Offered
11.1.5 AstraZeneca Recent Development
11.12 Nobel Ilac Sanayii Ve Ticaret
11.12.1 Nobel Ilac Sanayii Ve Ticaret Corporation Information
11.12.2 Nobel Ilac Sanayii Ve Ticaret Description, Business Overview and Total Revenue
11.12.3 Nobel Ilac Sanayii Ve Ticaret Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Nobel Ilac Sanayii Ve Ticaret Products Offered
11.12.5 Nobel Ilac Sanayii Ve Ticaret Recent Development
11.13 Accure Labs
11.13.1 Accure Labs Corporation Information
11.13.2 Accure Labs Description, Business Overview and Total Revenue
11.13.3 Accure Labs Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Accure Labs Products Offered
11.13.5 Accure Labs Recent Development
11.14 Cadila Pharmaceuticals
11.14.1 Cadila Pharmaceuticals Corporation Information
11.14.2 Cadila Pharmaceuticals Description, Business Overview and Total Revenue
11.14.3 Cadila Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Cadila Pharmaceuticals Products Offered
11.14.5 Cadila Pharmaceuticals Recent Development
11.15 Ethypharm
11.15.1 Ethypharm Corporation Information
11.15.2 Ethypharm Description, Business Overview and Total Revenue
11.15.3 Ethypharm Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Ethypharm Products Offered
11.15.5 Ethypharm Recent Development
11.16 Flagship Biotech International
11.16.1 Flagship Biotech International Corporation Information
11.16.2 Flagship Biotech International Description, Business Overview and Total Revenue
11.16.3 Flagship Biotech International Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Flagship Biotech International Products Offered
11.16.5 Flagship Biotech International Recent Development
11.17 Globela Pharma
11.17.1 Globela Pharma Corporation Information
11.17.2 Globela Pharma Description, Business Overview and Total Revenue
11.17.3 Globela Pharma Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Globela Pharma Products Offered
11.17.5 Globela Pharma Recent Development
11.18 Jodas Expoim
11.18.1 Jodas Expoim Corporation Information
11.18.2 Jodas Expoim Description, Business Overview and Total Revenue
11.18.3 Jodas Expoim Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Jodas Expoim Products Offered
11.18.5 Jodas Expoim Recent Development
11.19 Nishchay Pharmaceuticals
11.19.1 Nishchay Pharmaceuticals Corporation Information
11.19.2 Nishchay Pharmaceuticals Description, Business Overview and Total Revenue
11.19.3 Nishchay Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Nishchay Pharmaceuticals Products Offered
11.19.5 Nishchay Pharmaceuticals Recent Development
11.20 Sichuan Xieli Pharmaceutical
11.20.1 Sichuan Xieli Pharmaceutical Corporation Information
11.20.2 Sichuan Xieli Pharmaceutical Description, Business Overview and Total Revenue
11.20.3 Sichuan Xieli Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Sichuan Xieli Pharmaceutical Products Offered
11.20.5 Sichuan Xieli Pharmaceutical Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Gefitinib Market Estimates and Projections by Region
12.1.1 Global Gefitinib Sales Forecast by Regions 2021-2026
12.1.2 Global Gefitinib Revenue Forecast by Regions 2021-2026
12.2 North America Gefitinib Market Size Forecast (2021-2026)
12.2.1 North America: Gefitinib Sales Forecast (2021-2026)
12.2.2 North America: Gefitinib Revenue Forecast (2021-2026)
12.2.3 North America: Gefitinib Market Size Forecast by Country (2021-2026)
12.3 Europe Gefitinib Market Size Forecast (2021-2026)
12.3.1 Europe: Gefitinib Sales Forecast (2021-2026)
12.3.2 Europe: Gefitinib Revenue Forecast (2021-2026)
12.3.3 Europe: Gefitinib Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Gefitinib Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Gefitinib Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Gefitinib Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Gefitinib Market Size Forecast by Region (2021-2026)
12.5 Latin America Gefitinib Market Size Forecast (2021-2026)
12.5.1 Latin America: Gefitinib Sales Forecast (2021-2026)
12.5.2 Latin America: Gefitinib Revenue Forecast (2021-2026)
12.5.3 Latin America: Gefitinib Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Gefitinib Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Gefitinib Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Gefitinib Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Gefitinib Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Gefitinib Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Gefitinib Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Gefitinib Market Segments
Table 2. Ranking of Global Top Gefitinib Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gefitinib Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 10 Tables/Box
Table 5. Major Manufacturers of 30 Tables/Box
Table 6. Major Manufacturers of 90 Tables/Box
Table 7. COVID-19 Impact Global Market: (Four Gefitinib Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Gefitinib Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Gefitinib Players to Combat Covid-19 Impact
Table 12. Global Gefitinib Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 13. Global Gefitinib Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 14. Global Gefitinib Sales by Regions 2015-2020 (K Pcs)
Table 15. Global Gefitinib Sales Market Share by Regions (2015-2020)
Table 16. Global Gefitinib Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Gefitinib Sales by Manufacturers (2015-2020) (K Pcs)
Table 18. Global Gefitinib Sales Share by Manufacturers (2015-2020)
Table 19. Global Gefitinib Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Gefitinib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gefitinib as of 2019)
Table 21. Gefitinib Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Gefitinib Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Gefitinib Price (2015-2020) (USD/Pcs)
Table 24. Gefitinib Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Gefitinib Product Type
Table 26. Date of International Manufacturers Enter into Gefitinib Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Gefitinib Sales by Type (2015-2020) (K Pcs)
Table 29. Global Gefitinib Sales Share by Type (2015-2020)
Table 30. Global Gefitinib Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Gefitinib Revenue Share by Type (2015-2020)
Table 32. Gefitinib Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global Gefitinib Sales by Application (2015-2020) (K Pcs)
Table 34. Global Gefitinib Sales Share by Application (2015-2020)
Table 35. North America Gefitinib Sales by Country (2015-2020) (K Pcs)
Table 36. North America Gefitinib Sales Market Share by Country (2015-2020)
Table 37. North America Gefitinib Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Gefitinib Revenue Market Share by Country (2015-2020)
Table 39. North America Gefitinib Sales by Type (2015-2020) (K Pcs)
Table 40. North America Gefitinib Sales Market Share by Type (2015-2020)
Table 41. North America Gefitinib Sales by Application (2015-2020) (K Pcs)
Table 42. North America Gefitinib Sales Market Share by Application (2015-2020)
Table 43. Europe Gefitinib Sales by Country (2015-2020) (K Pcs)
Table 44. Europe Gefitinib Sales Market Share by Country (2015-2020)
Table 45. Europe Gefitinib Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Gefitinib Revenue Market Share by Country (2015-2020)
Table 47. Europe Gefitinib Sales by Type (2015-2020) (K Pcs)
Table 48. Europe Gefitinib Sales Market Share by Type (2015-2020)
Table 49. Europe Gefitinib Sales by Application (2015-2020) (K Pcs)
Table 50. Europe Gefitinib Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Gefitinib Sales by Region (2015-2020) (K Pcs)
Table 52. Asia Pacific Gefitinib Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Gefitinib Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Gefitinib Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Gefitinib Sales by Type (2015-2020) (K Pcs)
Table 56. Asia Pacific Gefitinib Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Gefitinib Sales by Application (2015-2020) (K Pcs)
Table 58. Asia Pacific Gefitinib Sales Market Share by Application (2015-2020)
Table 59. Latin America Gefitinib Sales by Country (2015-2020) (K Pcs)
Table 60. Latin America Gefitinib Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Gefitinib Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Gefitinib Revenue Market Share by Country (2015-2020)
Table 63. Latin America Gefitinib Sales by Type (2015-2020) (K Pcs)
Table 64. Latin America Gefitinib Sales Market Share by Type (2015-2020)
Table 65. Latin America Gefitinib Sales by Application (2015-2020) (K Pcs)
Table 66. Latin America Gefitinib Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Gefitinib Sales by Country (2015-2020) (K Pcs)
Table 68. Middle East and Africa Gefitinib Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Gefitinib Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Gefitinib Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Gefitinib Sales by Type (2015-2020) (K Pcs)
Table 72. Middle East and Africa Gefitinib Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Gefitinib Sales by Application (2015-2020) (K Pcs)
Table 74. Middle East and Africa Gefitinib Sales Market Share by Application (2015-2020)
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Major Businesses
Table 77. AstraZeneca Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. AstraZeneca Product
Table 79. AstraZeneca Recent Development
Table 80. Qilu Pharmaceutical Corporation Information
Table 81. Qilu Pharmaceutical Description and Major Businesses
Table 82. Qilu Pharmaceutical Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Qilu Pharmaceutical Product
Table 84. Qilu Pharmaceutical Recent Development
Table 85. Natco Pharma Corporation Information
Table 86. Natco Pharma Description and Major Businesses
Table 87. Natco Pharma Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Natco Pharma Product
Table 89. Natco Pharma Recent Development
Table 90. Celon Laboratories Corporation Information
Table 91. Celon Laboratories Description and Major Businesses
Table 92. Celon Laboratories Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Celon Laboratories Product
Table 94. Celon Laboratories Recent Development
Table 95. Hetero Drugs Corporation Information
Table 96. Hetero Drugs Description and Major Businesses
Table 97. Hetero Drugs Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Hetero Drugs Product
Table 99. Hetero Drugs Recent Development
Table 100. Dr Reddy's Laboratories Corporation Information
Table 101. Dr Reddy's Laboratories Description and Major Businesses
Table 102. Dr Reddy's Laboratories Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Dr Reddy's Laboratories Product
Table 104. Dr Reddy's Laboratories Recent Development
Table 105. Zuventus Healthcare Corporation Information
Table 106. Zuventus Healthcare Description and Major Businesses
Table 107. Zuventus Healthcare Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Zuventus Healthcare Product
Table 109. Zuventus Healthcare Recent Development
Table 110. United Biotech Corporation Information
Table 111. United Biotech Description and Major Businesses
Table 112. United Biotech Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. United Biotech Product
Table 114. United Biotech Recent Development
Table 115. Panacea Biotec Corporation Information
Table 116. Panacea Biotec Description and Major Businesses
Table 117. Panacea Biotec Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Panacea Biotec Product
Table 119. Panacea Biotec Recent Development
Table 120. Cipla Corporation Information
Table 121. Cipla Description and Major Businesses
Table 122. Cipla Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Cipla Product
Table 124. Cipla Recent Development
Table 125. Glenmark Pharmaceuticals Corporation Information
Table 126. Glenmark Pharmaceuticals Description and Major Businesses
Table 127. Glenmark Pharmaceuticals Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Glenmark Pharmaceuticals Product
Table 129. Glenmark Pharmaceuticals Recent Development
Table 130. Nobel Ilac Sanayii Ve Ticaret Corporation Information
Table 131. Nobel Ilac Sanayii Ve Ticaret Description and Major Businesses
Table 132. Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Nobel Ilac Sanayii Ve Ticaret Product
Table 134. Nobel Ilac Sanayii Ve Ticaret Recent Development
Table 135. Accure Labs Corporation Information
Table 136. Accure Labs Description and Major Businesses
Table 137. Accure Labs Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Accure Labs Product
Table 139. Accure Labs Recent Development
Table 140. Cadila Pharmaceuticals Corporation Information
Table 141. Cadila Pharmaceuticals Description and Major Businesses
Table 142. Cadila Pharmaceuticals Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Cadila Pharmaceuticals Product
Table 144. Cadila Pharmaceuticals Recent Development
Table 145. Ethypharm Corporation Information
Table 146. Ethypharm Description and Major Businesses
Table 147. Ethypharm Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. Ethypharm Product
Table 149. Ethypharm Recent Development
Table 150. Flagship Biotech International Corporation Information
Table 151. Flagship Biotech International Description and Major Businesses
Table 152. Flagship Biotech International Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 153. Flagship Biotech International Product
Table 154. Flagship Biotech International Recent Development
Table 155. Globela Pharma Corporation Information
Table 156. Globela Pharma Description and Major Businesses
Table 157. Globela Pharma Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 158. Globela Pharma Product
Table 159. Globela Pharma Recent Development
Table 160. Jodas Expoim Corporation Information
Table 161. Jodas Expoim Description and Major Businesses
Table 162. Jodas Expoim Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 163. Jodas Expoim Product
Table 164. Jodas Expoim Recent Development
Table 165. Nishchay Pharmaceuticals Corporation Information
Table 166. Nishchay Pharmaceuticals Description and Major Businesses
Table 167. Nishchay Pharmaceuticals Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 168. Nishchay Pharmaceuticals Product
Table 169. Nishchay Pharmaceuticals Recent Development
Table 170. Sichuan Xieli Pharmaceutical Corporation Information
Table 171. Sichuan Xieli Pharmaceutical Description and Major Businesses
Table 172. Sichuan Xieli Pharmaceutical Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 173. Sichuan Xieli Pharmaceutical Product
Table 174. Sichuan Xieli Pharmaceutical Recent Development
Table 175. Global Gefitinib Sales Forecast by Regions (2021-2026) (K Pcs)
Table 176. Global Gefitinib Sales Market Share Forecast by Regions (2021-2026)
Table 177. Global Gefitinib Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 178. Global Gefitinib Revenue Market Share Forecast by Regions (2021-2026)
Table 179. North America: Gefitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 180. North America: Gefitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Europe: Gefitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 182. Europe: Gefitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 183. Asia Pacific: Gefitinib Sales Forecast by Region (2021-2026) (K Pcs)
Table 184. Asia Pacific: Gefitinib Revenue Forecast by Region (2021-2026) (US$ Million)
Table 185. Latin America: Gefitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 186. Latin America: Gefitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 187. Middle East and Africa: Gefitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 188. Middle East and Africa: Gefitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 189. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 190. Key Challenges
Table 191. Market Risks
Table 192. Main Points Interviewed from Key Gefitinib Players
Table 193. Gefitinib Customers List
Table 194. Gefitinib Distributors List
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
Table 1. Gefitinib Market Segments
Table 2. Ranking of Global Top Gefitinib Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gefitinib Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 10 Tables/Box
Table 5. Major Manufacturers of 30 Tables/Box
Table 6. Major Manufacturers of 90 Tables/Box
Table 7. COVID-19 Impact Global Market: (Four Gefitinib Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Gefitinib Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Gefitinib Players to Combat Covid-19 Impact
Table 12. Global Gefitinib Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 13. Global Gefitinib Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 14. Global Gefitinib Sales by Regions 2015-2020 (K Pcs)
Table 15. Global Gefitinib Sales Market Share by Regions (2015-2020)
Table 16. Global Gefitinib Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Gefitinib Sales by Manufacturers (2015-2020) (K Pcs)
Table 18. Global Gefitinib Sales Share by Manufacturers (2015-2020)
Table 19. Global Gefitinib Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Gefitinib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gefitinib as of 2019)
Table 21. Gefitinib Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Gefitinib Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Gefitinib Price (2015-2020) (USD/Pcs)
Table 24. Gefitinib Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Gefitinib Product Type
Table 26. Date of International Manufacturers Enter into Gefitinib Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Gefitinib Sales by Type (2015-2020) (K Pcs)
Table 29. Global Gefitinib Sales Share by Type (2015-2020)
Table 30. Global Gefitinib Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Gefitinib Revenue Share by Type (2015-2020)
Table 32. Gefitinib Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global Gefitinib Sales by Application (2015-2020) (K Pcs)
Table 34. Global Gefitinib Sales Share by Application (2015-2020)
Table 35. North America Gefitinib Sales by Country (2015-2020) (K Pcs)
Table 36. North America Gefitinib Sales Market Share by Country (2015-2020)
Table 37. North America Gefitinib Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Gefitinib Revenue Market Share by Country (2015-2020)
Table 39. North America Gefitinib Sales by Type (2015-2020) (K Pcs)
Table 40. North America Gefitinib Sales Market Share by Type (2015-2020)
Table 41. North America Gefitinib Sales by Application (2015-2020) (K Pcs)
Table 42. North America Gefitinib Sales Market Share by Application (2015-2020)
Table 43. Europe Gefitinib Sales by Country (2015-2020) (K Pcs)
Table 44. Europe Gefitinib Sales Market Share by Country (2015-2020)
Table 45. Europe Gefitinib Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Gefitinib Revenue Market Share by Country (2015-2020)
Table 47. Europe Gefitinib Sales by Type (2015-2020) (K Pcs)
Table 48. Europe Gefitinib Sales Market Share by Type (2015-2020)
Table 49. Europe Gefitinib Sales by Application (2015-2020) (K Pcs)
Table 50. Europe Gefitinib Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Gefitinib Sales by Region (2015-2020) (K Pcs)
Table 52. Asia Pacific Gefitinib Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Gefitinib Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Gefitinib Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Gefitinib Sales by Type (2015-2020) (K Pcs)
Table 56. Asia Pacific Gefitinib Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Gefitinib Sales by Application (2015-2020) (K Pcs)
Table 58. Asia Pacific Gefitinib Sales Market Share by Application (2015-2020)
Table 59. Latin America Gefitinib Sales by Country (2015-2020) (K Pcs)
Table 60. Latin America Gefitinib Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Gefitinib Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Gefitinib Revenue Market Share by Country (2015-2020)
Table 63. Latin America Gefitinib Sales by Type (2015-2020) (K Pcs)
Table 64. Latin America Gefitinib Sales Market Share by Type (2015-2020)
Table 65. Latin America Gefitinib Sales by Application (2015-2020) (K Pcs)
Table 66. Latin America Gefitinib Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Gefitinib Sales by Country (2015-2020) (K Pcs)
Table 68. Middle East and Africa Gefitinib Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Gefitinib Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Gefitinib Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Gefitinib Sales by Type (2015-2020) (K Pcs)
Table 72. Middle East and Africa Gefitinib Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Gefitinib Sales by Application (2015-2020) (K Pcs)
Table 74. Middle East and Africa Gefitinib Sales Market Share by Application (2015-2020)
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Major Businesses
Table 77. AstraZeneca Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. AstraZeneca Product
Table 79. AstraZeneca Recent Development
Table 80. Qilu Pharmaceutical Corporation Information
Table 81. Qilu Pharmaceutical Description and Major Businesses
Table 82. Qilu Pharmaceutical Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Qilu Pharmaceutical Product
Table 84. Qilu Pharmaceutical Recent Development
Table 85. Natco Pharma Corporation Information
Table 86. Natco Pharma Description and Major Businesses
Table 87. Natco Pharma Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Natco Pharma Product
Table 89. Natco Pharma Recent Development
Table 90. Celon Laboratories Corporation Information
Table 91. Celon Laboratories Description and Major Businesses
Table 92. Celon Laboratories Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Celon Laboratories Product
Table 94. Celon Laboratories Recent Development
Table 95. Hetero Drugs Corporation Information
Table 96. Hetero Drugs Description and Major Businesses
Table 97. Hetero Drugs Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Hetero Drugs Product
Table 99. Hetero Drugs Recent Development
Table 100. Dr Reddy's Laboratories Corporation Information
Table 101. Dr Reddy's Laboratories Description and Major Businesses
Table 102. Dr Reddy's Laboratories Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Dr Reddy's Laboratories Product
Table 104. Dr Reddy's Laboratories Recent Development
Table 105. Zuventus Healthcare Corporation Information
Table 106. Zuventus Healthcare Description and Major Businesses
Table 107. Zuventus Healthcare Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Zuventus Healthcare Product
Table 109. Zuventus Healthcare Recent Development
Table 110. United Biotech Corporation Information
Table 111. United Biotech Description and Major Businesses
Table 112. United Biotech Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. United Biotech Product
Table 114. United Biotech Recent Development
Table 115. Panacea Biotec Corporation Information
Table 116. Panacea Biotec Description and Major Businesses
Table 117. Panacea Biotec Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Panacea Biotec Product
Table 119. Panacea Biotec Recent Development
Table 120. Cipla Corporation Information
Table 121. Cipla Description and Major Businesses
Table 122. Cipla Gefitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Cipla Product
Table 124. Cipla Recent Development
Table 125. Glenmark Pharmaceuticals Corporation Information
Table 126. Glenmark Pharmaceuticals Description and Major Businesses
Table 127. Glenmark Pharmaceuticals Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Glenmark Pharmaceuticals Product
Table 129. Glenmark Pharmaceuticals Recent Development
Table 130. Nobel Ilac Sanayii Ve Ticaret Corporation Information
Table 131. Nobel Ilac Sanayii Ve Ticaret Description and Major Businesses
Table 132. Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Nobel Ilac Sanayii Ve Ticaret Product
Table 134. Nobel Ilac Sanayii Ve Ticaret Recent Development
Table 135. Accure Labs Corporation Information
Table 136. Accure Labs Description and Major Businesses
Table 137. Accure Labs Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Accure Labs Product
Table 139. Accure Labs Recent Development
Table 140. Cadila Pharmaceuticals Corporation Information
Table 141. Cadila Pharmaceuticals Description and Major Businesses
Table 142. Cadila Pharmaceuticals Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Cadila Pharmaceuticals Product
Table 144. Cadila Pharmaceuticals Recent Development
Table 145. Ethypharm Corporation Information
Table 146. Ethypharm Description and Major Businesses
Table 147. Ethypharm Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. Ethypharm Product
Table 149. Ethypharm Recent Development
Table 150. Flagship Biotech International Corporation Information
Table 151. Flagship Biotech International Description and Major Businesses
Table 152. Flagship Biotech International Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 153. Flagship Biotech International Product
Table 154. Flagship Biotech International Recent Development
Table 155. Globela Pharma Corporation Information
Table 156. Globela Pharma Description and Major Businesses
Table 157. Globela Pharma Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 158. Globela Pharma Product
Table 159. Globela Pharma Recent Development
Table 160. Jodas Expoim Corporation Information
Table 161. Jodas Expoim Description and Major Businesses
Table 162. Jodas Expoim Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 163. Jodas Expoim Product
Table 164. Jodas Expoim Recent Development
Table 165. Nishchay Pharmaceuticals Corporation Information
Table 166. Nishchay Pharmaceuticals Description and Major Businesses
Table 167. Nishchay Pharmaceuticals Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 168. Nishchay Pharmaceuticals Product
Table 169. Nishchay Pharmaceuticals Recent Development
Table 170. Sichuan Xieli Pharmaceutical Corporation Information
Table 171. Sichuan Xieli Pharmaceutical Description and Major Businesses
Table 172. Sichuan Xieli Pharmaceutical Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 173. Sichuan Xieli Pharmaceutical Product
Table 174. Sichuan Xieli Pharmaceutical Recent Development
Table 175. Global Gefitinib Sales Forecast by Regions (2021-2026) (K Pcs)
Table 176. Global Gefitinib Sales Market Share Forecast by Regions (2021-2026)
Table 177. Global Gefitinib Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 178. Global Gefitinib Revenue Market Share Forecast by Regions (2021-2026)
Table 179. North America: Gefitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 180. North America: Gefitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Europe: Gefitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 182. Europe: Gefitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 183. Asia Pacific: Gefitinib Sales Forecast by Region (2021-2026) (K Pcs)
Table 184. Asia Pacific: Gefitinib Revenue Forecast by Region (2021-2026) (US$ Million)
Table 185. Latin America: Gefitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 186. Latin America: Gefitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 187. Middle East and Africa: Gefitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 188. Middle East and Africa: Gefitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 189. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 190. Key Challenges
Table 191. Market Risks
Table 192. Main Points Interviewed from Key Gefitinib Players
Table 193. Gefitinib Customers List
Table 194. Gefitinib Distributors List
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Gefitinib Product Picture
Figure 2. Global Gefitinib Sales Market Share by Type in 2020 & 2026
Figure 3. 10 Tables/Box Product Picture
Figure 4. 30 Tables/Box Product Picture
Figure 5. 90 Tables/Box Product Picture
Figure 6. Global Gefitinib Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Drug Center
Figure 10. Other
Figure 11. Gefitinib Report Years Considered
Figure 12. Global Gefitinib Market Size 2015-2026 (US$ Million)
Figure 13. Global Gefitinib Sales 2015-2026 (K Pcs)
Figure 14. Global Gefitinib Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Gefitinib Sales Market Share by Region (2015-2020)
Figure 16. Global Gefitinib Sales Market Share by Region in 2019
Figure 17. Global Gefitinib Revenue Market Share by Region (2015-2020)
Figure 18. Global Gefitinib Revenue Market Share by Region in 2019
Figure 19. Global Gefitinib Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Gefitinib Revenue in 2019
Figure 21. Gefitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Gefitinib Sales Market Share by Type (2015-2020)
Figure 23. Global Gefitinib Sales Market Share by Type in 2019
Figure 24. Global Gefitinib Revenue Market Share by Type (2015-2020)
Figure 25. Global Gefitinib Revenue Market Share by Type in 2019
Figure 26. Global Gefitinib Market Share by Price Range (2015-2020)
Figure 27. Global Gefitinib Sales Market Share by Application (2015-2020)
Figure 28. Global Gefitinib Sales Market Share by Application in 2019
Figure 29. Global Gefitinib Revenue Market Share by Application (2015-2020)
Figure 30. Global Gefitinib Revenue Market Share by Application in 2019
Figure 31. North America Gefitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Gefitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Gefitinib Sales Market Share by Country in 2019
Figure 34. North America Gefitinib Revenue Market Share by Country in 2019
Figure 35. U.S. Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Gefitinib Market Share by Type in 2019
Figure 40. North America Gefitinib Market Share by Application in 2019
Figure 41. Europe Gefitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Gefitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Gefitinib Sales Market Share by Country in 2019
Figure 44. Europe Gefitinib Revenue Market Share by Country in 2019
Figure 45. Germany Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Gefitinib Market Share by Type in 2019
Figure 56. Europe Gefitinib Market Share by Application in 2019
Figure 57. Asia Pacific Gefitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Gefitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Gefitinib Sales Market Share by Region in 2019
Figure 60. Asia Pacific Gefitinib Revenue Market Share by Region in 2019
Figure 61. China Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Gefitinib Market Share by Type in 2019
Figure 84. Asia Pacific Gefitinib Market Share by Application in 2019
Figure 85. Latin America Gefitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Gefitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Gefitinib Sales Market Share by Country in 2019
Figure 88. Latin America Gefitinib Revenue Market Share by Country in 2019
Figure 89. Mexico Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Gefitinib Market Share by Type in 2019
Figure 96. Latin America Gefitinib Market Share by Application in 2019
Figure 97. Middle East and Africa Gefitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Gefitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Gefitinib Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Gefitinib Revenue Market Share by Country in 2019
Figure 101. Turkey Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Gefitinib Market Share by Type in 2019
Figure 108. Middle East and Africa Gefitinib Market Share by Application in 2019
Figure 109. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Natco Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Celon Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Hetero Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Dr Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Zuventus Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. United Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Panacea Biotec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Nobel Ilac Sanayii Ve Ticaret Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Accure Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Cadila Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Ethypharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Flagship Biotech International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. Globela Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. Jodas Expoim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 127. Nishchay Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 128. Sichuan Xieli Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 129. North America Gefitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 130. North America Gefitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Europe Gefitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 132. Europe Gefitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Asia Pacific Gefitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 134. Asia Pacific Gefitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 135. Latin America Gefitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 136. Latin America Gefitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 137. Middle East and Africa Gefitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 138. Middle East and Africa Gefitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 139. Porter's Five Forces Analysis
Figure 140. Channels of Distribution
Figure 141. Distributors Profiles
Figure 142. Bottom-up and Top-down Approaches for This Report
Figure 143. Data Triangulation
Figure 144. Key Executives Interviewed
Figure 1. Gefitinib Product Picture
Figure 2. Global Gefitinib Sales Market Share by Type in 2020 & 2026
Figure 3. 10 Tables/Box Product Picture
Figure 4. 30 Tables/Box Product Picture
Figure 5. 90 Tables/Box Product Picture
Figure 6. Global Gefitinib Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Drug Center
Figure 10. Other
Figure 11. Gefitinib Report Years Considered
Figure 12. Global Gefitinib Market Size 2015-2026 (US$ Million)
Figure 13. Global Gefitinib Sales 2015-2026 (K Pcs)
Figure 14. Global Gefitinib Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Gefitinib Sales Market Share by Region (2015-2020)
Figure 16. Global Gefitinib Sales Market Share by Region in 2019
Figure 17. Global Gefitinib Revenue Market Share by Region (2015-2020)
Figure 18. Global Gefitinib Revenue Market Share by Region in 2019
Figure 19. Global Gefitinib Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Gefitinib Revenue in 2019
Figure 21. Gefitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Gefitinib Sales Market Share by Type (2015-2020)
Figure 23. Global Gefitinib Sales Market Share by Type in 2019
Figure 24. Global Gefitinib Revenue Market Share by Type (2015-2020)
Figure 25. Global Gefitinib Revenue Market Share by Type in 2019
Figure 26. Global Gefitinib Market Share by Price Range (2015-2020)
Figure 27. Global Gefitinib Sales Market Share by Application (2015-2020)
Figure 28. Global Gefitinib Sales Market Share by Application in 2019
Figure 29. Global Gefitinib Revenue Market Share by Application (2015-2020)
Figure 30. Global Gefitinib Revenue Market Share by Application in 2019
Figure 31. North America Gefitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Gefitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Gefitinib Sales Market Share by Country in 2019
Figure 34. North America Gefitinib Revenue Market Share by Country in 2019
Figure 35. U.S. Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Gefitinib Market Share by Type in 2019
Figure 40. North America Gefitinib Market Share by Application in 2019
Figure 41. Europe Gefitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Gefitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Gefitinib Sales Market Share by Country in 2019
Figure 44. Europe Gefitinib Revenue Market Share by Country in 2019
Figure 45. Germany Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Gefitinib Market Share by Type in 2019
Figure 56. Europe Gefitinib Market Share by Application in 2019
Figure 57. Asia Pacific Gefitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Gefitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Gefitinib Sales Market Share by Region in 2019
Figure 60. Asia Pacific Gefitinib Revenue Market Share by Region in 2019
Figure 61. China Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Gefitinib Market Share by Type in 2019
Figure 84. Asia Pacific Gefitinib Market Share by Application in 2019
Figure 85. Latin America Gefitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Gefitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Gefitinib Sales Market Share by Country in 2019
Figure 88. Latin America Gefitinib Revenue Market Share by Country in 2019
Figure 89. Mexico Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Gefitinib Market Share by Type in 2019
Figure 96. Latin America Gefitinib Market Share by Application in 2019
Figure 97. Middle East and Africa Gefitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Gefitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Gefitinib Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Gefitinib Revenue Market Share by Country in 2019
Figure 101. Turkey Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Gefitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Gefitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Gefitinib Market Share by Type in 2019
Figure 108. Middle East and Africa Gefitinib Market Share by Application in 2019
Figure 109. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Natco Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Celon Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Hetero Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Dr Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Zuventus Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. United Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Panacea Biotec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Nobel Ilac Sanayii Ve Ticaret Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Accure Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Cadila Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Ethypharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Flagship Biotech International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. Globela Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. Jodas Expoim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 127. Nishchay Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 128. Sichuan Xieli Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 129. North America Gefitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 130. North America Gefitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Europe Gefitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 132. Europe Gefitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Asia Pacific Gefitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 134. Asia Pacific Gefitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 135. Latin America Gefitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 136. Latin America Gefitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 137. Middle East and Africa Gefitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 138. Middle East and Africa Gefitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 139. Porter's Five Forces Analysis
Figure 140. Channels of Distribution
Figure 141. Distributors Profiles
Figure 142. Bottom-up and Top-down Approaches for This Report
Figure 143. Data Triangulation
Figure 144. Key Executives Interviewed